p. 267-279
Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis
Kunwar Shailbhai, Surendra Dheer, Donald Picker, Gurmeet Kaur, Edward A. Sausville and Gary S. Jacob
Abstract
Full Text (IP)
p. 281-289
Inhibition of TF gene expression by antisense oligonucleotides in different cancer cell lines
Yvonne Forster and Bernd Schwenzer
Abstract
Full Text (IP)
p. 291-303
The importance of the CXCL12 – CXCR4 chemokine ligand – receptor interaction in prostate cancer metastasis
Manit Arya, Hitendra Rh Patel, Claire McGurk, Roger Tatoud, Helmut Klocker, John Masters, Magali Williamson
Abstract
Full Text (IP)
p. 305-316
Radioimmunotherapy in non-Hodgkin’s lymphoma: focus on 90Y-ibritumomab 305tiuxetan (Zevalin®)
Christine A. White
Abstract
Full Text (IP)
p. 317-325
Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor rctivation by imatinib mesylate
Faye M. Johnson, Peiying Yang, Robert A. Newman and Nicholas J. Donato
Abstract
Full Text (IP)
p. 327-334
Serum protein profiling of lung cancer patients
Carla Mendes Maciel, Marco Eduardo Machado Paschoal, Marcia Tie Kawamura, Maria Da Gloria Da Costa Carvalho
Abstract
Full Text (IP)
p. 335-342
Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp
Bo Han, Gengyin Zhou, Ginghui Zhang, Jing Zhang, Xiaojuan Wang, Weihua Tang, Kennichi Kakudo
Abstract
Full Text (IP)
p. 343-348
Phase II study of nedaplatin and irinotecan for elderly patients with advanced non-small cell lung cancer
Fumihiro Oshita, Kouzo Yamada, Haruhiro Saito, Kazumasa Noda, Nobuyuki Hamanaka, Mizuki Ikehara
Abstract
Full Text (IP)
Perspective
Maria V. Korshunova
Full Text (IP)